Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

3.45
Delayed Data
As of Aug 21
 +0.15 / +4.55%
Today’s Change
1.10
Today|||52-Week Range
5.30
+155.56%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$65.3M

Company Description

Cancer Genetics, Inc. is an early-stage diagnostics company that engages in the development and commercializes proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. Its developments include DNA-FISH Probes, CGH Microarrays and next-generation sequencing treatments. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Information

Cancer Genetics, Inc.
Meadows Office Complex
Rutherford New Jersey 07070
P:(201) 528-9200
Investor Relations:

Employees

Shareholders

Mutual fund holders3.32%
Individual stakeholders16.49%
Other institutional12.90%

Top Executives

John A. RobertsChairman & Chief Operating Officer
Panna L. SharmaPresident, Chief Executive Officer & Director
Rita ShaknovichMedical Director & VP-Hematopathology
Weiyi ChenDirector-Molecular Diagnostics
Pal Singh-KahlonCytogenetics Director